Global Long-term Outcomes and Real-World Evaluation of Dexcom Continuous Glucose Monitoring System (Dexcom GLOW)

Sponsor
DexCom, Inc.
Study ID
NCT07681024
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Diabetes

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Dexcom CGM (Continuous Glucose Monitor) — DEVICE
    Use Dexcom CGM according to approved commercial use. Evaluate HbA1c over time.

Study Details

Global Registry study

Key Dates

First listed
Jul 2, 2026
Start date
Jun 15, 2026
Status verified
Jun 2026
Primary completion
May 1, 2030
Completion
May 1, 2030

Study Design

Enrollment
5,000 participants (estimated)

Primary Outcome Measure

Evaluations [ Time Frame: Up to 8 years ]

Central Contacts

Related Studies